Clinical trial
Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing…
NCT00248495 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00248495 |
|---|---|
| Title | Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer |
| Official title | Molecular and Genetic Changes in Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) Following Neoadjuvant Chemotherapy With Cisplatin and Alimta - Phase II Study |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, pemetrexed disodium, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Enrollment | 38 |
| Start date | Jun 8, 2005 |
| Primary completion | Apr 29, 2011 |
| Completion | Apr 5, 2017 |
| First posted | Nov 4, 2005 |
| Last update posted | Jul 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: